CDC40

cell division cycle 40, the group of Spliceosomal Bact complex|Spliceosomal P complex|WD repeat domain containing|NTC associated proteins|Spliceosomal C complex

Basic information

Region (hg38): 6:110180141-110254275

Links

ENSG00000168438NCBI:51362OMIM:605585HGNC:17350Uniprot:O60508AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • pontocerebellar hypoplasia, type 15 (Limited), mode of inheritance: Unknown
  • pontocerebellar hypoplasia, type 15 (Limited), mode of inheritance: AR

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CDC40 gene.

  • not_specified (44 variants)
  • not_provided (2 variants)
  • Pontocerebellar_hypoplasia,_type_15 (2 variants)
  • Congenital_pontocerebellar_hypoplasia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDC40 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015891.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
missense
1
clinvar
45
clinvar
1
clinvar
47
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 1 45 2 0

Highest pathogenic variant AF is 0.0000043540676

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CDC40protein_codingprotein_codingENST00000368932 1574135
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9790.0206125729081257370.0000318
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.671723030.5680.00001413819
Missense in Polyphen40105.620.37871326
Synonymous0.680941030.9150.000004721043
Loss of Function4.60533.90.1470.00000159431

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001160.000116
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002640.0000264
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Associates with the spliceosome late in the splicing pathway and may function in the second step of pre-mRNA splicing. {ECO:0000269|PubMed:9830021}.;
Pathway
Spliceosome - Homo sapiens (human);mRNA Processing;Gene expression (Transcription);RNA Polymerase II Transcription;Metabolism of RNA;Cleavage of Growing Transcript in the Termination Region ;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing;mRNA 3,-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA (Consensus)

Recessive Scores

pRec
0.153

Intolerance Scores

loftool
0.224
rvis_EVS
-0.16
rvis_percentile_EVS
41.91

Haploinsufficiency Scores

pHI
0.281
hipred
Y
hipred_score
0.786
ghis
0.587

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.988

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cdc40
Phenotype

Gene ontology

Biological process
mRNA splicing, via spliceosome;RNA export from nucleus;mRNA export from nucleus;RNA splicing;mRNA 3'-end processing
Cellular component
nucleus;nucleoplasm;spliceosomal complex;U2-type catalytic step 2 spliceosome;catalytic step 2 spliceosome
Molecular function
RNA binding;protein binding